NOD2/RIG-I Activating Inarigivir Adjuvant Enhances the Efficacy of BCG Vaccine Against Tuberculosis in MiceArshad Khan, Chinnaswamy Jagannath|Frontiers in Immunology|2020Cited by 25
CD44 receptor targeted nanoparticles augment immunity against tuberculosis in miceVipul K. Singh, Arshad Khan|Journal of Controlled Release|2022Cited by 15